cytochalasin-b and Tendinopathy

cytochalasin-b has been researched along with Tendinopathy* in 1 studies

Other Studies

1 other study(ies) available for cytochalasin-b and Tendinopathy

ArticleYear
Mitochondrial transfer from bone mesenchymal stem cells protects against tendinopathy both in vitro and in vivo.
    Stem cell research & therapy, 2023, 04-26, Volume: 14, Issue:1

    Although mesenchymal stem cells (MSCs) have been effective in tendinopathy, the mechanisms by which MSCs promote tendon healing have not been fully elucidated. In this study, we tested the hypothesis that MSCs transfer mitochondria to injured tenocytes in vitro and in vivo to protect against Achilles tendinopathy (AT).. Bone marrow MSCs and H. MSCs successfully donated healthy mitochondria to in vitro and in vivo damaged tenocytes. Interestingly, mitochondrial transfer was almost completely blocked by co-treatment with cytochalasin B. Transfer of MSC-derived mitochondria decreased apoptosis, promoted proliferation, and restored mitochondrial function in H. MSCs rescued distressed tenocytes from apoptosis by transferring mitochondria. This provides evidence that mitochondrial transfer is one mechanism by which MSCs exert their therapeutic effects on damaged tenocytes.

    Topics: Achilles Tendon; Animals; Cells, Cultured; Cytochalasin B; Hydrogen Peroxide; Mesenchymal Stem Cells; Mitochondria; Rats; Tendinopathy

2023